Concepedia

Maggie Fedgchin

MF

13

Publications

3.1K

Citations

13

H-Index

2015

Active since

Affiliations

Janssen (United States)(Current)

Janssen (Belgium)

University of Pennsylvania

Janssen Scientific Affairs (United States)

Centre for Human Drug Research

Maggie Fedgchin is an author at Janssen (United States) specializing in depression, psychopharmacology, and social sciences.

Top concepts

Publications per year

2015–2021

13

Publications

13

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression

Ella Daly, Jaskaran Singh, Maggie Fedgchin et al. · JAMA Psychiatry · 2017 · 670 citations · Full text

Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study

Carla M. Canuso, Jaskaran Singh, Maggie Fedgchin et al. · American Journal of Psychiatry · 2018 · 648 citations · Full text

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)

Maggie Fedgchin, Madhukar H. Trivedi, Ella Daly et al. · The International Journal of Neuropsychopharmacology · 2019 · 560 citations · Full text

A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression

Jaskaran Singh, Maggie Fedgchin, Ella Daly et al. · American Journal of Psychiatry · 2016 · 511 citations · Full text

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study

Jaskaran Singh, Maggie Fedgchin, Ella Daly et al. · Biological Psychiatry · 2015 · 435 citations · Full text

Rows per page

1–5 of 13